Treatment for fetal sacrococcygeal teratomas (SCT) has shown excellent prognosis following surgical resection. The team at the Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment aims to continuously improve the long-term outcomes of fetus’ with SCT through research studies and collaborations aimed at improving current SCT management.

Prior noteworthy publications

• Gebb JS, Khalek N, Qamar H, Johnson MP, Oliver ER, Coleman BG, Peranteau WH, Hedrick HL, Flake AW, Adzick NS, Moldenhauer JS. High Tumor Volume to Fetal Weight Ratio Is Associated with Worse Fetal Outcomes and Increased Maternal Risk in Fetuses with Sacrococcygeal Teratoma. Fetal Diagn Ther. 2019;45(2):94-101. 
• Partridge EA, Canning D, Long C, Peranteau WH, Hedrick HL, Adzick NS, Flake AW. Urologic and anorectal complications of sacrococcygeal teratomas: prenatal and postnatal predictors. J Pediatr Surg. 2014 Jan;49(1):139-43.
• Roybal JL, Moldenhauer JS, Khalek N, Bebbington MW, Johnson MP, Hedrick HL, et al. Early delivery as an alternative management strategy for selected high-risk fetal sacrococcygeal teratomas. J Pediatr Surg. 2011 Jul;46(7):1325-32.
• Wilson RD, Hedrick H, Flake AW, Johnson MP, Bebbington MW, Mann S, Rychik J, Liechty K, Adzick NS. Sacrococcygeal teratomas: prenatal surveillance, growth and pregnancy outcome. Fetal Diagn Ther. 2009;25(1):15-20.
• Tran KM, Flake AW, Kalawadia NV, Maxwell LG, Rehman MA. Emergent excision of a prenatally diagnosed sacrococcygeal teratoma. Paediatr Anaesth. 2008 May;18(5):431-4.